China NT Pharma Group Company Limited (HKG:1011)

Market Cap	283.18M
Revenue (ttm)	40.40M
Net Income (ttm)	-56.78M
Shares Out	674.25M
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	921,000
Average Volume	250,893
Open	0.4150
Previous Close	0.4000
Day's Range	0.4050 - 0.4200
52-Week Range	0.1930 - 0.7900
Beta	-1.76
RSI	42.74
Earnings Date	Aug 29, 2025

About HKG:1011

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China and Hong Kong. It operates in two segments, Digital Services and Sales Agency Service. The company manufactures, sells, and trades in prescription medicines. It also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is head...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 22
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1011

Financial Performance

In 2024, HKG:1011's revenue was 37.96 million, an increase of 415.34% compared to the previous year's 7.37 million. Losses were -53.36 million, -62.84% less than in 2023.

Financial numbers in CNY